Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans

Background/Objectives: Marburg virus (MARV) is the etiological agent of Marburg Virus Disease (MVD), a rare but severe hemorrhagic fever disease with high case fatality rates in humans. Smaller outbreaks have frequently been reported in countries in Africa over the last few years, and confirmed huma...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Alina Tscherne, Georgia Kalodimou, Alexandra Kupke, Cornelius Rohde, Astrid Freudenstein, Sylvia Jany, Satendra Kumar, Gerd Sutter, Verena Krähling, Stephan Becker, Asisa Volz
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2024-11-01
Schriftenreihe:	Vaccines
Schlagworte:	Modified Vaccinia virus Ankara (MVA) viral vector vaccine emerging viruses rapid vaccine development Marburg virus
Online-Zugang:	https://www.mdpi.com/2076-393X/12/12/1316
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!